Oncology & Cancer

Team learns how to predict triple negative breast cancer recurrence

Indiana University School of Medicine researchers have discovered how to predict whether triple negative breast cancer will recur, and which women are likely to remain disease-free. They will present their findings on December ...

Oncology & Cancer

Patient-reported outcomes predict aromatase inhibitor adherence

If you want to predict which breast cancer patients will most likely stop taking aromatase inhibitors, check out their own responses to the health questions patients commonly answer in cancer clinical trials, according to ...

Oncology & Cancer

Breast cancer patients to be evaluated for genetic testing

According to a statement on behalf of the American College of Medical Genetics and Genomics (ACMG) published Dec. 13 in the organization's official journal, Genetics in Medicine, there is insufficient evidence to recommend ...

Oncology & Cancer

Many cancer patients interested in pathology consultations

(HealthDay)—When surveyed, a majority of cancer patients expressed interest in participating in a patient-pathologist consultation program, according to a study recently published in the Archives of Pathology & Laboratory ...

Oncology & Cancer

Breast cancer recurrence score has different implications for men

The TAILORx study published last year offered good news for women with early-stage ER-positive breast cancer who scored at intermediate risk for recurrence according to a genetic assay test. The study indicated that chemotherapy ...

page 1 from 23